Are you Dr. De Ravin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 6 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
# Crc
Bethesda, MD 20892Phone+1 301-496-6772Fax+1 301-402-8859
Summary
- Dr. Suk De Ravin, MD is an infectious disease specialist in Bethesda, Maryland. She is currently licensed to practice medicine in Maryland.
Education & Training
University of New South Wales Faculty of MedicineClass of 1987
Certifications & Licensure
MD State Medical License 2009 - 2018
Publications & Presentations
PubMed
- 19 citationsCRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytes.Julie Brault, Taylor Q. Liu, Ezekiel Bello, Siyuan Liu, Colin L. Sweeney
Blood. 2021-06-04 - 44 citationsEnhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cells.Suk See De Ravin, Julie Brault, Ronald J. Meis, Siyuan Liu, Linhong Li
Blood. 2021-05-13 - 10 citationsCRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells.Julie Brault, Taylor Liu, Siyuan Liu, Amanda Lawson, Uimook Choi
Frontiers in Immunology. 2022-01-01
Press Mentions
Gene Editing Approach Paves the Way to First-in-Human Clinical Trial for Rare Genetic DiseaseOctober 10th, 2024
Grant Support
- Gene Therapy Clinical Trials For X-Linked Severe Combined ImmunodeficiencyNational Institute Of Allergy And Infectious Diseases2009–2011
- Clinical Diagnostic Studies And Treatment Of Patients With Immune DeficienciesNational Institute Of Allergy And Infectious Diseases2009–2011
- Gene Therapy Clinical Trials For X-Linked Severe Combined ImmunodeficiencyNational Institute Of Allergy And Infectious Diseases2008
- Clinical Diagnostic Studies And Treatment Of Patients With Immune DeficienciesNational Institute Of Allergy And Infectious Diseases2008
